General Information of the Compound
| Compound ID |
CP0853989
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-(4-Fluorophenyl)-3-{2-hydroxy-3-[4-(naphthalen-1-yl)-piperazin-1-yl]propyl}-5-methylimidazolidine-2,4-dione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H29FN4O3
|
||||||||||||||||||
| Molecular Weight |
476.552
|
||||||||||||||||||
| Canonical SMILES |
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3cccc4ccccc34)CC2)C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H29FN4O3/c1-27(20-9-11-21(28)12-10-20)25(34)32(26(35)29-27)18-22(33)17-30-13-15-31(16-14-30)24-8-4-6-19-5-2-3-7-23(19)24/h2-12,22,33H,13-18H2,1H3,(H,29,35)
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZBOIINMMAKPIPZ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Protein ID: PT01005, D(2) dopamine receptor